PQ32 is an anti-tumor agent targeting c-MYCPu27 and KRASG-quadruplexes. It hinders the proliferation of tumor cells, arrests the cell cycle at the G2 phase, and induces apoptosis (apoptosis). PQ32 suppresses the expression of c-MYC and KRAS genes. It can inhibit tumor growth in mice and is applicable for research in cancers such as lymphoma, breast cancer, lung cancer, hepatocellular carcinoma, and colorectal cancer.
Target-Kategorie:
Ras|||c-Myc|||Apoptosis
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
